IL6 and breast cancer: The overexpression of MCT-1 in triple-negative breast cancer activates MCT-1/miR-34a/IL-6/IL-6R signaling, disrupting the normal structure of breast cancer epithelial glands and inducing EMT, thus promoting the polarization of TAMs toward the M2 subtype [67].